Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trialDavid Marín, Katayoun Rezvani, Ye Li et al.|Nature Medicine|2024Cited by 452
Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experienceYasuhiro Oki, Jason R. Westin, Michael Wang et al.|British Journal of Haematology|2014Cited by 364
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantationPhilippe Armand, Alex F. Herrera, Yi‐Bin Chen et al.|Blood|2019Cited by 187
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancerIan McNiece, Elizabeth J. Shpall, Roy B. Jones et al.|Blood|2000Cited by 159
CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicityUri Greenbaum, Sairah Ahmed, Paolo Strati et al.|Blood Advances|2021Cited by 146